AKT1 and type 2 diabetes mellitus: For example, in T2DM model, OA administration was found to reverse hyperglycemia and normalize blood glucose levels [217,218], improve hepatic insulin resistance [219], and suppress hepatic glucose production via the Akt/FoxO1 pathways [220].